Acute myeloid leukemia patients with NUP98::NSD1 showing initially poor treatment response can benefit from FLT3 inhibitors and venetoclax as well as HSCT

被引：6

作者：

Sun, Haimin ^{[1
]}

Yan, Han ^{[2
]}

Yan, Zeying ^{[1
]}

Zhu, Yongmei ^{[2
]}

Yang, Guang ^{[2
]}

Zhang, Sujiang ^{[1
,2
]}

机构：

[1] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Hematol, Sch Med, Ruijin Rd 2 197, Shanghai, Peoples R China

[2] Shanghai Jiao Tong Univ, State Key Lab Med Gen, Natl Res Ctr Translat Med Shanghai, Shanghai Inst Hematol,Ruijin Hosp,Sch Med, Ruijin Rd 2 197, Shanghai, Shanghai, Peoples R China

来源：

ANNALS OF HEMATOLOGY | 2023年 / 102卷 / 02期

关键词：

NUP98/NSD1;

D O I：

10.1007/s00277-022-05047-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：473 / 475

页数：3

共 21 条

[21] NUP98-NSD1 Fusion in Association with FLT3-ITD Mutation Identifies a Prognostically Relevant Subgroup of Pediatric Acute Myeloid Leukemia Patients Suitable for Monitoring by Real Time Quantitative PCR
Akiki, Susanna
Dyer, Sara A.
Grimwade, David
Ivey, Adam
Abou-Zeid, Nervana
Borrow, Julian
Jeffries, Sally
Caddick, Judith
Newell, Hayley
Begum, Suriya
Tawana, Kiran
Mason, Joanne
Velangi, Mark
Griffiths, Michael
GENES CHROMOSOMES & CANCER, 2013, 52 (11): : 1053 - 1064

← 1 2 3 →